Renaissance Technologies LLC Buys New Shares in Privia Health Group, Inc. (NASDAQ:PRVA)

Renaissance Technologies LLC bought a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 64,500 shares of the company's stock, valued at approximately $1,121,000. Renaissance Technologies LLC owned approximately 0.05% of Privia Health Group as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Blair William & Co. IL grew its holdings in shares of Privia Health Group by 125.4% in the first quarter. Blair William & Co. IL now owns 51,564 shares of the company's stock valued at $1,010,000 after acquiring an additional 28,689 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in shares of Privia Health Group by 27.1% in the first quarter. Oppenheimer Asset Management Inc. now owns 234,991 shares of the company's stock valued at $4,603,000 after acquiring an additional 50,042 shares in the last quarter. Peregrine Capital Management LLC grew its holdings in shares of Privia Health Group by 11.5% in the second quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company's stock valued at $5,461,000 after acquiring an additional 32,311 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Privia Health Group by 2.5% in the fourth quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company's stock valued at $259,740,000 after acquiring an additional 274,345 shares in the last quarter. Finally, FDx Advisors Inc. grew its holdings in shares of Privia Health Group by 71.6% in the first quarter. FDx Advisors Inc. now owns 20,067 shares of the company's stock valued at $393,000 after acquiring an additional 8,374 shares in the last quarter. 94.48% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Robert W. Baird upped their price objective on Privia Health Group from $23.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, August 26th. Evercore ISI dropped their price objective on Privia Health Group from $23.00 to $20.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 9th. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $28.00 price objective on shares of Privia Health Group in a research note on Wednesday, August 14th. Two investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $24.86.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA traded down $0.39 during trading on Monday, hitting $17.20. 470,317 shares of the company were exchanged, compared to its average volume of 867,035. The company has a market cap of $2.05 billion, a PE ratio of 117.27, a P/E/G ratio of 4.14 and a beta of 0.76. The stock has a 50 day moving average of $19.23 and a 200 day moving average of $18.42. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $24.35.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.02). Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The company had revenue of $422.30 million for the quarter, compared to analysts' expectations of $411.50 million. During the same quarter in the prior year, the company earned $0.06 EPS. The company's revenue was up 2.2% on a year-over-year basis. Sell-side analysts forecast that Privia Health Group, Inc. will post 0.16 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the sale, the chief executive officer now owns 247,771 shares in the company, valued at approximately $4,583,763.50. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 14.20% of the stock is currently owned by company insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.